The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10439 malaria professionals are enjoying the free benefits of MalariaWorld today

artemether-lumefantrine

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos

June 13, 2012 - 14:59 -- Patrick Sampao
Author(s): 
Mayxay M, Khanthavong M, Chanthongthip O, Imwong M, Pongvongsa T, Hongvanthong B, Phompida S, Vanisaveth V, White NJ, Newton PN
Reference: 
Malaria Journal 2012, 11:184 (8 June 2012)

MalariaWorldOf 630 patients with P. falciparum enrolled in the trial of thiamin treatment, 549 (87%, 357 children [less than or equal to]15 years and 192 adults) were included in this study.

Region: 
Medical Condition: 

Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania

May 29, 2012 - 12:05 -- Kabogo Ndegwa
Author(s): 
Färnert A, Ursing J, Tolfvenstam T, Rono J, Karlsson L, Sparrelid E, Lindegårdh N
Reference: 
Malaria Journal 2012, 11:176 (25 May 2012)

MalariaWorldArtemether-lumefantrine is currently first-line therapy of Plasmodium falciparum malaria in many countries.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixedspecies malaria in Gabon

April 26, 2012 - 13:05 -- Kabogo Ndegwa
Author(s): 
Mombo-Ngoma G, Kleine C, Basra A, Würbel H, Diop DA, Capan M, Adegnika AA, Kurth F, Mordmüller B, Joanny F, Kremsner PG, Ramharter M, Bélard S
Reference: 
Malaria Journal 2012, 11:120 (19 April 2012)

MalariaWorldThis first systematic assessment of artemether-lumefantrine treatment for P. malariae, P. ovale and mixed-species malaria demonstrated a high cure rate of 100% and a favourable tolerability profile, and thus lends support to the practice of treating non-falciparum or mixed-species malaria, or indeed all clinically suspected cases of malaria, with artemetherlumefantrine in Gabon.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Case Report: Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine

March 30, 2012 - 13:24 -- Patrick Sampao
Author(s): 
Corpolongo A, De Nardo P, Ghirga P, Gentilotti E, Bellagamba R, Tommasi C, Paglia M, Nicastri E, Narciso P
Reference: 
Malaria Journal 2012, 11:91 (27 March 2012)

MalariaWorldThis paper describes the case of an HIV-infected patient with severe falciparum malaria who was diagnosed with haemolytic anaemia after treatment with oral artemether-lumefantrine.

Medical Treatment: 

Open Access | Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework

March 19, 2012 - 15:11 -- Patrick Sampao
Author(s): 
Amani Thomas Mori and Eliangiringa Amos Kaale
Reference: 
Implementation Science 2012, 7:18

MalariaWorldIn our understanding, this is the first study to evaluate priority-setting decisions for new drugs in Tanzania against the accountability for reasonableness framework.

Country: 

Short Report: Efficacy of Artemether-Lumefantrine in Area of High Malaria Endemicity in India and Its Correlation with Blood Concentration of Lumefantrine

March 9, 2012 - 13:45 -- Patrick Sampao
Author(s): 
Neena Valecha, Suman Mohanty, Prakriti Srivastava, Surya Sharma, Prajesh Tyagi, Yngve Bergqvist and Pascal Ringwald
Reference: 
Am J Trop Med Hyg 2012 86:395-397

MalariaWorldThis study was conducted to correlate blood concentrations of lumefantrine with treatment outcome for patients with Plasmodium falciparum malaria when the drug was given without specific instructions for administration with food.

Medical Condition: 
Medical Treatment: 

Open Access | Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania

March 6, 2012 - 06:43 -- Kabogo Ndegwa
Author(s): 
Kamugisha E, Jing S, Minde M, Kataraihya J, Kongola G, Kironde F, Swedberg G
Reference: 
Malaria Journal 2012, 11:58 (27 February 2012)

MalariaWorldThe efficacy of artemether-lumefantrine for treatment of uncomplicated malaria is still high in the study area although the rate of re-infection is higher than previously reported.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya

February 14, 2012 - 07:27 -- Kabogo Ndegwa
Author(s): 
Sudoi RK, Githinji S, Nyandigisi A, Muturi A, Snow RW, Zurovac D
Reference: 
Malaria Journal 2012, 11:37 (8 February 2012)

MalariaWorldDespite lower levels of AL stock-outs compared to the reports in 2008, the stock-outs at Kenyan facilities during 2010-2011 are still substantial and of particular worry for the most detrimental:- simultaneous absence of any AL pack.

Continent: 
Country: 
Medical Condition: 
Medical Treatment: 

Randomized, Prospective, Three-Arm Study to Confirm the Auditory Safety and Efficacy of Artemether-Lumefantrine in Colombian Patients with Uncomplicated Plasmodium falciparum Malaria

January 11, 2012 - 08:20 -- Patrick Sampao
Author(s): 
Gabriel Carrasquilla, Clemencia Barón, Edwin M. Monsell, Marc Cousin, Verena Walter, Gilbert Lefèvre, Oliver Sander and Laurel M. Fisher
Reference: 
Am J Trop Med Hyg 2012 86:75-83

MalariaWorldThe safety of artemether-lumefantrine in patients with acute, uncomplicated Plasmodium falciparum malaria was investigated prospectively using the auditory brainstem response (ABR) and pure-tone thresholds.

Country: 
Medical Condition: 
Medical Treatment: 

Open Access | Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial

December 15, 2011 - 15:48 -- Kabogo Ndegwa
Author(s): 
Tine RC, Faye B, Ndour CT, Ndiaye JL, Ndiaye M, Bassene C, Magnussen P, Bygbjerg IC, Sylla K, Ndour JD, Gaye O
Reference: 
Malaria Journal 2011, 10:358 (13 December 2011)

http://www.pnas.org/content/108/50/20113.abstractCombining IPTc and HMM can provide significant additional benefit in preventing clinical episodes of malaria as well as anaemia among children in Senegal.

Country: 
Medical Condition: 

Pages

Subscribe to RSS - artemether-lumefantrine